Exploring the Microbiome-Kynurenine Axis in Mild Cognitive Impairment: From Gut to Brain
Journal of Integrative Neuroscience · 15.06.2026 · 25 (6)
DOI: 10.31083/jin48660 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Integrative Neuroscience, online erschienen am 15.06.2026. Verfasst von Jiaxing Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Acupuncture & Tuina and Rehabilitation, Hunan University of Chinese Medicine, 410208 Changsha, Hunan, China. Hauptthemen laut MEDLINE: Kynurenine, Gastrointestinal Microbiome, Cognitive Dysfunction, Brain. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Projects of the science and technology innovation Program of Hunan Province, Scientific Research Project of Hunan Provincial Health Commission, State Administration of Traditional Chinese Medicine 2022 Youth Qihuang Scholars Training Program (National Letter of Traditional Chinese Medicine Education).
Abstract (Originalsprache)
Mild cognitive impairment (MCI) represents a critical prodromal stage of Alzheimer’s disease. This review synthesizes current evidence to present a coherent pathological cascade driving MCI progression: gut microbiota dysbiosis (e.g., enrichment of Prevotella and depletion of Akkermansia) triggers a butyrate deficit and compromise of intestinal integrity, leading to systemic inflammation. This inflammatory milieu upregulates indoleamine 2,3-dioxygenase 1 (IDO1), shifting tryptophan metabolism toward the kynurenine pathway and resulting in the dominance of neurotoxic branches (3-hydroxykynurenine [3-HK], quinolinic acid [QUIN]) over neuroprotective kynurenic acid (KYNA). This metabolic imbalance promotes N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity, oxidative stress, and neuroinflammation, which collectively precipitate synaptic dysfunction and cognitive decline. We explicitly highlight this “gut-immune-metabolic” vicious cycle as the core framework of MCI pathology. Targeting this cycle through a dual strategy—restoring microbial diversity and pharmacologically inhibiting the IDO1/kynurenine 3-monooxygenase (KMO) enzymes—represents a promising therapeutic approach to delay the transition from MCI to dementia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Acupuncture & Tuina and Rehabilitation, Hunan University of Chinese Medicine, 410208 Changsha, Hunan, China.
- Department of Preventive Center, The Second Affiliated Hospital of Hunan University of Chinese Medicine, 410010 Changsha, Hunan, China.
- Acupuncture Department, The Second Affiliated Hospital of Hunan University of Chinese Medicine, 410010 Changsha, Hunan, China.
Förderung
- Projects of the science and technology innovation Program of Hunan Province
- Scientific Research Project of Hunan Provincial Health Commission
- State Administration of Traditional Chinese Medicine 2022 Youth Qihuang Scholars Training Program (National Letter of Traditional Chinese Medicine Education)
- Hunan Provincial Graduate Joint Cultivation Base for Acupuncture-Moxibustion and Tuina of Hunan University of Chinese Medicine (Hunan Provincial Department of…
- Acupuncture Bioinformation and Smart Wellness Innovation and Entrepreneurship Education Center of Hunan University of Chinese Medicine (Hunan Provincial Depart…
- Innovative Graduate Cultivation Base for Chinese Medicine Sub-health of Hunan University of Chinese Medicine (University Administrative Research Document)
- Hunan Provincial Graduate Joint Cultivation Base for Acupuncture-Moxibustion and Tuina of Hunan University of Chinese Medicine
- Acupuncture Bioinformation and Smart Wellness Innovation and Entrepreneurship Education Center of Hunan University of Chinese Medicine
Zitieren
APA
Zhu, J., Xie, H., Ouyang, Y., Zhu, T., Liu, Q., Liu, W., Xiong, S., & Liu, M. (2026). Exploring the Microbiome-Kynurenine Axis in Mild Cognitive Impairment: From Gut to Brain. Journal of Integrative Neuroscience, 25(6). https://doi.org/10.31083/jin48660
Vancouver
Zhu J, Xie H, Ouyang Y, Zhu T, Liu Q, Liu W, et al. Exploring the Microbiome-Kynurenine Axis in Mild Cognitive Impairment: From Gut to Brain. Journal of Integrative Neuroscience. 2026;25(6). doi:10.31083/jin48660
BibTeX
@article{Zhu2026,
author = {Zhu, Jiaxing and Xie, Haihua and Ouyang, Yingke and Zhu, Ting and Liu, Qianyan and Liu, Weiai and Xiong, Shulin and Liu, Mi},
title = {Exploring the Microbiome-Kynurenine Axis in Mild Cognitive Impairment: From Gut to Brain},
journal = {Journal of Integrative Neuroscience},
year = {2026},
volume = {25},
number = {6},
doi = {10.31083/jin48660}
}
EUVIMED